Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05064449 · ClinicalTrials.gov registry record · Phase 1
A Study of Soticlestat With Itraconazole and Mefenamic Acid in Healthy Adults
A Phase 1 study, sponsored by Takeda.
- Completed
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
NCT05064449 is a Phase 1 study that has completed, run by Takeda. The registered enrollment target is 28 participants.
The verdict
NCT05064449, a Phase 1 study, has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
The main aim of this study is to check how itraconazole and mefenamic acid affect the way soticlestat is processed by the body. The study will have 2 parts. Participants can only participate in one study part. Part 1: Participants will check into the study clinic to receive soticlestat, four days later they will begin receiving itraconazole and will stay in the clinic for 11 more days, receiving soticlestat in combination with itraconazole on one of those days. Participants will be contacted about 8 days after leaving the clinic for follow-up. Part 2: Participants will check into the study clinic to receive soticlestat, four days later they will begin receiving mefenamic acid and will stay in the clinic for 7 more days, receiving soticlestat in combination with mefenamic acid on one of those days.. Participants will be contacted about 9 days after leaving the clinic for follow-up.
Interventions
- DRUG Itraconazole
- DRUG Soticlestat
- DRUG Mefenamic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2021-10-14 |
| Est. Completion | 2021-11-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05064449
The ClinicalTrials.gov registry entry for NCT05064449 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Itraconazole is the first listed.
NCT05064449 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05064449 about?
NCT05064449 is a clinical study titled "A Study of Soticlestat With Itraconazole and Mefenamic Acid in Healthy Adults". The main aim of this study is to check how itraconazole and mefenamic acid affect the way soticlestat is processed by the body. The study will have 2 parts. Participants can only participate in one study part. Part 1: Participants will check into the study clinic to receive soticlestat, four days ...
What is the current status of trial NCT05064449?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2021-10-14. Estimated completion is 2021-11-30.
What interventions are being tested in trial NCT05064449?
The interventions under investigation include: Itraconazole (DRUG), Soticlestat (DRUG), Mefenamic acid (DRUG).
Who is sponsoring clinical trial NCT05064449?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.